How I treat hairy cell leukemia von Grever, Michael R.

Volltext

BTKC481S-Mediated Resistance to Ibrutinib in Chronic Lymphocytic Leukemia von Woyach, Jennifer A, Ruppert, Amy S, Guinn, Daphne, Lehman, Amy, Blachly, James S, Lozanski, Arletta, Heerema, Nyla A, Zhao, Weiqiang, Coleman, Joshua, Jones, Daniel, Abruzzo, Lynne, Gordon, Amber, Mantel, Rose, Smith, Lisa L, McWhorter, Samantha, Davis, Melanie, Doong, Tzyy-Jye, Ny, Fan, Lucas, Margaret, Chase, Weihong, Jones, Jeffrey A, Flynn, Joseph M, Maddocks, Kami, Rogers, Kerry, Jaglowski, Samantha, Andritsos, Leslie A, Awan, Farrukh T, Blum, Kristie A, Grever, Michael R, Lozanski, Gerard, Johnson, Amy J, Byrd, John C

Volltext

Curcumin down-regulates DNA methyltransferase 1 and plays an anti-leukemic role in acute myeloid leukemia von Yu, Jianhua, Peng, Yong, Wu, Lai-Chu, Xie, Zhiliang, Deng, Youcai, Hughes, Tiffany, He, Shun, Mo, XiaoKui, Chiu, Ming, Wang, Qi-En, He, Xiaoming, Liu, Shujun, Grever, Michael R, Chan, Kenneth K, Liu, Zhongfa

Volltext

Second cancer incidence in CLL patients receiving BTK inhibitors von Bond, David A., Huang, Ying, Fisher, James L., Ruppert, Amy S., Owen, Dwight H., Bertino, Erin M., Rogers, Kerry A., Bhat, Seema A., Grever, Michael R., Jaglowski, Samantha M., Maddocks, Kami J., Byrd, John C., Woyach, Jennifer A.

Volltext

Clinical response and miR-29b predictive significance in older AML patients treated with a 10-day schedule of decitabine von Blum, William, Garzon, Ramiro, Klisovic, Rebecca B, Schwind, Sebastian, Walker, Alison, Geyer, Susan, Liu, Shujun, Havelange, Violaine, Becker, Heiko, Schaaf, Larry, Mickle, Jon, Devine, Hollie, Kefauver, Cheryl, Devine, Steven M, Chan, Kenneth K, Heerema, Nyla A, Bloomfield, Clara D, Grever, Michael R, Byrd, John C, Villalona-Calero, Miguel, Croce, Carlo M, Marcucci, Guido

Volltext

Two-inhibitor salvage therapy for hairy cell leukemia von Grever, Michael R.

Volltext

Guidelines for the development and incorporation of biomarker studies in early clinical trials of novel agents von Dancey, Janet E, Dobbin, Kevin K, Groshen, Susan, Jessup, J Milburn, Hruszkewycz, Andrew H, Koehler, Maria, Parchment, Ralph, Ratain, Mark J, Shankar, Lalitha K, Stadler, Walter M, True, Lawrence D, Gravell, Amy, Grever, Michael R

Volltext

Therapeutic potential of the translation inhibitor silvestrol in hepatocellular cancer von Kogure, Takayuki, Kinghorn, A Douglas, Yan, Irene, Bolon, Brad, Lucas, David M, Grever, Michael R, Patel, Tushar

Volltext

Low levels of miR-92b/96 induce PRMT5 translation and H3R8/H4R3 methylation in mantle cell lymphoma von Pal, Sharmistha, Baiocchi, Robert A, Byrd, John C, Grever, Michael R, Jacob, Samson T, Sif, Saïd

Volltext

Phase III Trial of Fludarabine Plus Cyclophosphamide Compared With Fludarabine for Patients With Previously Untreated Chronic Lymphocytic Leukemia: US Intergroup Trial E2997 von FLINN, Ian W, NEUBERG, Donna S, TALLMAN, Martin S, GREVER, Michael R, DEWALD, Gordon W, BENNETT, John M, PAIETTA, Elisabeth M, HUSSEIN, Mohamad A, APPELBAUM, Frederick R, LARSON, Richard A, MOORE, Dennis F

Volltext

Clinical and pharmacodynamic activity of bortezomib and decitabine in acute myeloid leukemia von Blum, William, Schwind, Sebastian, Tarighat, Somayeh S., Geyer, Susan, Eisfeld, Ann-Kathrin, Whitman, Susan, Walker, Alison, Klisovic, Rebecca, Byrd, John C., Santhanam, Ramasamy, Wang, Hongyan, Curfman, John P., Devine, Steven M., Jacob, Samson, Garr, Celia, Kefauver, Cheryl, Perrotti, Danilo, Chan, Kenneth K., Bloomfield, Clara D., Caligiuri, Michael A., Grever, Michael R., Garzon, Ramiro, Marcucci, Guido

Volltext

PRMT5 Is Upregulated in Malignant and Metastatic Melanoma and Regulates Expression of MITF and p27Kip1 von Nicholas, Courtney, Yang, Jennifer, Peters, Sara B., Bill, Matthew A., Baiocchi, Robert A., Yan, Fengting, Sïf, Saïd, Tae, Sookil, Gaudio, Eugenio, Wu, Xin, Grever, Michael R., Young, Gregory S., Lesinski, Gregory B.

Volltext

Phase I Study of Decitabine Alone or in Combination With Valproic Acid in Acute Myeloid Leukemia von BLUM, William, KLISOVIC, Rebecca B, PLASS, Christoph, DEVINE, Steven M, HEEREMA, Nyla A, MURGO, Anthony, CHAN, Kenneth K, GREVER, Michael R, BYRD, John C, MARCUCCI, Guido, HACKANSON, Bjoern, ZHONGFA LIU, SHUJUN LIU, DEVINE, Hollie, VUKOSAVLJEVIC, Tamara, HUYNH, Lenguyen, LOZANSKI, Gerard, KEFAUVER, Cheryl

Volltext

Comprehensive Assessment of Genetic and Molecular Features Predicting Outcome in Patients With Chronic Lymphocytic Leukemia: Results From the US Intergroup Phase III Trial E2997 von GREVER, Michael R, LUCAS, David M, PAIETTA, Elisabeth, JELINEK, Diane F, GRIBBEN, John G, BYRD, John C, DEWALD, Gordon W, NEUBERG, Donna S, REED, John C, KITADA, Shinichi, FLINN, Ian W, TALLMAN, Martin S, APPELBAUM, Frederick R, LARSON, Richard A

Volltext

Downregulation of Death-Associated Protein Kinase 1 (DAPK1) in Chronic Lymphocytic Leukemia von Raval, Aparna, Tanner, Stephan M., Byrd, John C., Angerman, Elizabeth B., Perko, James D., Chen, Shih-Shih, Hackanson, Björn, Grever, Michael R., Lucas, David M., Matkovic, Jennifer J., Lin, Thomas S., Kipps, Thomas J., Murray, Fiona, Weisenburger, Dennis, Sanger, Warren, Lynch, Jane, Watson, Patrice, Jansen, Mary, Yoshinaga, Yuko, Rosenquist, Richard, de Jong, Pieter J., Coggill, Penny, Beck, Stephan, Lynch, Henry, de la Chapelle, Albert, Plass, Christoph

Volltext

Prognostic significance of translocations in the presence of mutated IGHV and of cytogenetic complexity at diagnosis of chronic lymphocytic leukemia von Heerema, Nyla A, Muthusamy, Natarajan, Zhao, Qiuhong, Ruppert, Amy S, Breidenbach, Heather, Andritsos, Leslie A, Grever, Michael R, Maddocks, Kami J, Woyach, Jennifer, Awan, Farrukh, Long, Meixiao, Gordon, Amber, Coombes, Caitlin, Byrd, John C

Volltext

PRMT5 is upregulated in malignant and metastatic melanoma and regulates expression of MITF and p27(Kip1.) von Nicholas, Courtney, Yang, Jennifer, Peters, Sara B, Bill, Matthew A, Baiocchi, Robert A, Yan, Fengting, Sïf, Saïd, Tae, Sookil, Gaudio, Eugenio, Wu, Xin, Grever, Michael R, Young, Gregory S, Lesinski, Gregory B

Volltext

Phase II Study of Flavopiridol in Relapsed Chronic Lymphocytic Leukemia Demonstrating High Response Rates in Genetically High-Risk Disease von Lin, Thomas S., Ruppert, Amy S., Johnson, Amy J., Fischer, Beth, Heerema, Nyla A., Andritsos, Leslie A., Blum, Kristie A., Flynn, Joseph M., Jones, Jeffrey A., Hu, Weihong, Moran, Mollie E., Mitchell, Sarah M., Smith, Lisa L., Wagner, Amy J., Raymond, Chelsey A., Schaaf, Larry J., Phelps, Mitch A., Villalona-Calero, Miguel A., Grever, Michael R., Byrd, John C.

Volltext

Modern Strategies for Hairy Cell Leukemia von Grever, Michael R, Lozanski, Gerard

Volltext

Select High-Risk Genetic Features Predict Earlier Progression Following Chemoimmunotherapy With Fludarabine and Rituximab in Chronic Lymphocytic Leukemia: Justification for Risk-Ad... von BYRD, John C, GRIBBEN, John G, PETERSON, Bercedis L, GREVER, Michael R, LOZANSKI, Gerard, LUCAS, David M, LAMPSON, Ben, LARSON, Richard A, CALIGIURI, Michael A, HEEREMA, Nyla A

Volltext